Health Ranger Report: The shocking truth about VENOM PEPTIDES in drugs and cosmetics

Derived from reptiles like the Gila monster, venom peptides are increasingly used in weight-loss drugs (e.g., Ozempic, Wegovy) and anti-aging skincare products, marketed for their hormone-mimicking properties. Experts warn that venom peptides can cause turbo-charged cancer growth, neurological damage and mental health issues like psychotic breaks, with research linking venom to accelerated cancer growth in … Continue reading Health Ranger Report: The shocking truth about VENOM PEPTIDES in drugs and cosmetics

Novo Nordisk makes absurd new health claims about Wegovy weight loss medication, which is synthesized based on REPTILIAN venom peptides

The market for the popular weight loss drug Wegovy (semaglutide) is expanding after Novo Nordisk, the Denmark-based pharmaceutical giant that manufactures it, issued new claims that the controversial pharmaceutical injection supposedly also helps to prevent heart attack, stroke and early death. Conveniently for the company, Wegovy allegedly works against a variety of cardiovascular problems that just so … Continue reading Novo Nordisk makes absurd new health claims about Wegovy weight loss medication, which is synthesized based on REPTILIAN venom peptides

QUACKERY: NY Times says injecting yourself with lizard venom peptides can prevent COVID deaths

The media is abuzz with new claims that the popular obesity drug Wegovy is helping fat people to avoid death from the Wuhan coronavirus (COVID-19). Like other GLP-1 drugs, Wegovy is synthesized from venom peptides of the Gila Monster reptile creature. As Business Insider reports, "It all started back in the early 1990s, when government researcher Dr. John Eng … Continue reading QUACKERY: NY Times says injecting yourself with lizard venom peptides can prevent COVID deaths

Diabetes and obesity drugs linked to thyroid cancer

The European Medicines Agency (EMA), the European Union's (EU) version of the Food and Drug Administration (FDA), issued a drug safety signal this week about the elevated thyroid cancer risk associated with certain classes of pharmaceuticals for Type 2 diabetes and obesity. Semaglutide, the active ingredient found in the widely used anti-diabetes and anti-obesity drugs Ozempic and … Continue reading Diabetes and obesity drugs linked to thyroid cancer